Ptc Therapeutics (PTCT) Current Leases: 2019-2025
Historic Current Leases for Ptc Therapeutics (PTCT) over the last 6 years, with Sep 2025 value amounting to $11.8 million.
- Ptc Therapeutics' Current Leases fell 16.32% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year decrease of 16.32%. This contributed to the annual value of $10.4 million for FY2024, which is 20.30% down from last year.
- According to the latest figures from Q3 2025, Ptc Therapeutics' Current Leases is $11.8 million, which was up 0.72% from $11.7 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Current Leases ranged from a high of $14.6 million in Q1 2024 and a low of $7.1 million during Q3 2021.
- Its 3-year average for Current Leases is $12.0 million, with a median of $11.7 million in 2025.
- In the last 5 years, Ptc Therapeutics' Current Leases surged by 75.48% in 2021 and then fell by 21.33% in 2025.
- Ptc Therapeutics' Current Leases (Quarterly) stood at $7.3 million in 2021, then rose by 28.83% to $9.4 million in 2022, then surged by 38.76% to $13.0 million in 2023, then decreased by 20.30% to $10.4 million in 2024, then decreased by 16.32% to $11.8 million in 2025.
- Its Current Leases was $11.8 million in Q3 2025, compared to $11.7 million in Q2 2025 and $11.5 million in Q1 2025.